Compare OGN & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | DAC |
|---|---|---|
| Founded | 1923 | 1972 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2020 | 2006 |
| Metric | OGN | DAC |
|---|---|---|
| Price | $13.76 | $158.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $11.25 | ★ $164.50 |
| AVG Volume (30 Days) | ★ 2.0M | 147.8K |
| Earning Date | 11-09-2026 | 11-16-2026 |
| Dividend Yield | 0.58% | ★ 2.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | N/A | $3.24 |
| Revenue Next Year | $2.51 | $1.63 |
| P/E Ratio | $14.48 | ★ $4.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $87.62 |
| 52 Week High | $13.83 | $172.76 |
| Indicator | OGN | DAC |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 49.85 |
| Support Level | $13.46 | $151.00 |
| Resistance Level | $13.77 | $163.64 |
| Average True Range (ATR) | 0.04 | 3.81 |
| MACD | -0.00 | -1.14 |
| Stochastic Oscillator | 34.78 | 23.36 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.